Price T Rowe Associates Inc Kura Oncology, Inc. Transaction History
Price T Rowe Associates Inc
- $836 Billion
- Q2 2024
A detailed history of Price T Rowe Associates Inc transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 23,054 shares of KURA stock, worth $444,711. This represents 0.0% of its overall portfolio holdings.
Number of Shares
23,054
Previous 20,148
14.42%
Holding current value
$444,711
Previous $430,000
10.47%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding KURA
# of Institutions
181Shares Held
80.2MCall Options Held
148KPut Options Held
63K-
Suvretta Capital Management, LLC New York, NY7.07MShares$136 Million6.08% of portfolio
-
Black Rock Inc. New York, NY6.97MShares$134 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA5.81MShares$112 Million4.23% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY5.41MShares$104 Million2.34% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY4.54MShares$87.6 Million3.78% of portfolio
About Kura Oncology, Inc.
- Ticker KURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 66,893,000
- Market Cap $1.29B
- Description
- Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...